Express News | Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (Viloxazine) in Canada

BreakingsDec 17 05:30

Knight Therapeutics Announces Filing of New Drug Submission for Qelbree (Viloxazine) in Canada

GlobeNewswireDec 17 05:30

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Simply Wall StDec 14 20:33

Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Supernus Pharmaceuticals (SUPN) and Skye Bioscience (SKYE)

TipRanksDec 6 20:21 · Ratings

Piper Sandler Sticks to Their Hold Rating for Supernus Pharmaceuticals (SUPN)

TipRanksDec 6 20:20 · Ratings

Screening For Black Friday Bargains In The Stock Market

BenzingaDec 3 22:21